BamSEC and AlphaSense Join Forces
Learn More

Taysha Gene Therapies Inc.

NASDAQ: TSHA    
Share price (12/20/24): $1.85    
Market cap (12/20/24): $379 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-3 18 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 20 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 20 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.2
from S-3 55 pages Taysha Gene Therapies, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.1
from 10-Q 6 pages Description of Taysha Gene Therapies, Inc. Common Stock
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Warrant to Purchase Common Stock Taysha Gene Therapies, Inc
12/34/56
EX-4.1
from 8-K 18 pages Pre-Funded Warrant to Purchase Common Stock Taysha Gene Therapies, Inc
12/34/56
EX-4.5
from S-3 19 pages Common Stock Purchase Warrant Taysha Gene Therapies, Inc
12/34/56
EX-4.4
from S-3 46 pages Securities Purchase Agreement
12/34/56
EX-4.6
from S-3 18 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 20 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.4
from S-3 20 pages Taysha Gene Therapies, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Taysha Gene Therapies, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.2
from S-3 55 pages Taysha Gene Therapies, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.2
from 10-K 4 pages Description of Taysha Gene Therapies, Inc. Common Stock
12/34/56
EX-4.1
from S-1 122 pages Certain Information Has Been Excluded From This Agreement (Indicated by “[***]”) Because Taysha Gene Therapies, Inc. Has Determined Such Information (I) Is Not Material and (II) Would Be Competitively Harmful if Publicly Disclosed. Amended and Restated Investors’ Rights Agreement
12/34/56